Journal of Clinical Oncology
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Journal of Clinical Oncology
Jul 25, 2024, 14:02 |
Insight
Erman Akkus: Should up-front SRS be added to TKI in brain metastatic EGFR/ALK positive NSCLC?
Erman Akkus, Medical Oncologist at Ankara University, shared a paper by Luke R.G. Pike et al. on…
Jul 25, 2024, 08:58 |
Insight
Marleen Kok: How do we get from one-size-fits-all to personalized treatment for TNBC
Marleen Kok, Breast Medical Oncologist at the Netherlands Cancer Institute, shared on X: "Today from…
Jul 22, 2024, 02:26 |
Insight
New Chapter in Ewing Sarcoma Treatment - The story of TK216
Shushan Hovsepyan shared a post on LinkedIn about a recent paper by Paul Meyers et…
Jul 21, 2024, 15:37 |
Insight
Neoadjuvant osimertinib for resectable EGFR NSCLC
Stephen V Liu shared on X a recent paper by Collin M. Blakely et al.…
Jul 21, 2024, 13:36 |
Blog
Rami Manochakian: Neoadjuvant osimertinib in stage I-IIIA EGFRm NSCLC did not meet primary endpoint
Rami Manochakian shared a post on X: ''Hot off the press. Neoadjuvant Osimertinib for the…
Jul 20, 2024, 22:54 |
Blog
David S. Miller: Why Cisplatin should not be added to radiotherapy for certain recurrent Endometrial Cancer
David Scott Miller, Gynaecologic Oncologist and Professor at Department of Obstetrics and Gynaecology at UT…
Jul 20, 2024, 12:53 |
Insight
Cyclophosphamide–Based GVHD Prophylaxis Reduces Outcome Disparity in Transplants
CIBMTR shared a post on X about a recent paper. . Authors: Brian C. Shaffer,…
Jul 19, 2024, 13:20 |
Blog
Alexios Matikas: We show for the first time the superiority of dose dense versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer
Alexios Matikas, Associate Professor of Oncology at Karolinska Institute, shared on LinkedIn: "Dose dense is…
Jul 18, 2024, 10:41 |
Insight
Systemic Therapy in Breast Cancer
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared on X about…
Jul 17, 2024, 23:36 |
Blog
Ishwaria Subbiah: Discussion on dissemination of evidence-based care of older adults with cancer with CARG
Ishwaria Subbiah shared on LinkedIn: "Superb discussion within our Cancer and Aging Research Group (CARG) core…
Jul 17, 2024, 21:52 |
Blog
Ishwaria Subbiah: Superb discussion on dissemination of evidence-based care of older adults with cancer
Ishwaria Subbiah shared a post on X: ''Superb discussion within our Cancer and Aging Research…
Jul 16, 2024, 13:55 |
Blog
5 papers to read suggested by Vivek Subbiah
We are presenting articles suggested by Vivek Subbiah: 1.'Pancreatic Cancer Surveillance and Survival of High-Risk…
Jul 13, 2024, 22:16 |
Insight
Erman Akkus: Management of cancer-related fatigue - ASCO guideline
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X about a…
Jul 9, 2024, 07:25 |
Insight
Piotr Wysocki: Checkpoint inhibitor and TKI combinations in GU malignancies
Piotr Wysocki recently posted on LinkedIn: "A phase I study (Apolo AB et al. J Clin…
Jul 8, 2024, 14:29 |
Blog
Shahrin Ahmed: A new radiotherapy technique for treating head and neck cancer
Shahrin Ahmed, medical specialist at Canadian Cancer Society, shared on X: "A new radiotherapy technique…
Jul 6, 2024, 12:24 |
Career
Omnia Korani: I have been accepted into the JCO Trainee Reviewer Mentoring Program
Omnia Korani, Assistant Lecturer at the National Cancer Institute, shared a post on LinkedIn: "Exciting…
Jul 5, 2024, 13:47 |
Insight
Andrea Apolo: Very proud of this Clinical Trial of Cabozantinib/Nivolumab published at JCO
Shilpa Gupta shared a post by Andrea Apolo, adding: "Huge congrats Andrea Apolo, leading this…
Jul 5, 2024, 06:54 |
Blog
Paolo Tarantino: Nearly 1000 downloads in less than a week for our ATEMPT 5-year publication
Paolo Tarantino, posted on X: "Nearly 1000 downloads in less than a week for our…
Jul 4, 2024, 03:53 |
Blog
Sarah Waliany: Reviewing the TRUST-1 trial investigating taletrectinib
Sarah Waliany, Thoracic Oncology Fellow at Mass General Cancer Center, shared the following post by…
Jul 3, 2024, 23:57 |
Blog
Ajay Major: The newly-developed NLPHL prognostic score
Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder and President…
Jul 3, 2024, 14:37 |
Insight
Jarushka Naidoo: Phase III RESILIENT Trial of Liposomal Irinotecan v Topotecan in 2L SCLC
Jarushka Naidoo shared a post on X: “Phase III RESILIENT Trial of Liposomal Irinotecan v…
Jul 2, 2024, 10:32 |
Insight
Trastuzumab emtansine (T-DM1) is highly effective in preventing stage 1 HER2-positive breast cancer from recurring - MedEdge MEA
MedEdge MEA shared a post on LinkedIn: . "A year of treatment with a medicine…
Jul 2, 2024, 09:15 |
Blog
Implementation of ChildGICR education programme on Cancer Registry Development - IARC
IARC shared a post on LinkedIn: “Researchers from International Agency for Research on Cancer (IARC) and…
Jul 1, 2024, 15:23 |
Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
Jun 29, 2024, 06:38 |
Blog
Ajay Major: Methylphenidate versus piperonyl butoxide RCT for cancer related fatigue
Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder and…
Jun 29, 2024, 05:30 |
Insight
Zainab Shinkafi-Bagudu: Renewed Commitments to Eliminate Cervical Cancer
Zainab Shinkafi-Bagudu shared a post on X: . "Following the first…
Jun 29, 2024, 05:21 |
Insight
Piotr Wysocki: Adjuvant endocrine treatment in single and unemployed young breast cancer patients
Piotr Wysocki recently posted on LinkedIn: "The study by Julie A. Schmidt et al. published online in…
Jun 28, 2024, 13:17 |
Blog
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
Zainab Shinkafi-Bagudu shared a post on LinkedIn: . "Following…
Jun 25, 2024, 16:01 |
Insight
Paolo Tarantino: Phase 1 trial of the HER2 topo1 ADC SHR-A1811 out in Journal of Clinical Oncology
Paolo Tarantino shared on X: . "Phase 1 trial of the HER2 topo1 ADC SHR-A1811…
Jun 25, 2024, 14:07 |
Insight
Piotr Wysocki: Minimally invasive surgery is out of the question in cervical cancer
Piotr Wysocki recently posted on LinkedIn: "Pedro Ramirez et al. published the results of the phase…
Jun 23, 2024, 19:16 |
Insight
Joshua Richter: Amazing Paper on Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma
Joshua Richter, Associate Professor of Medicine, Hematology, and Medical Oncology at The Tisch Cancer Institute,…
Jun 22, 2024, 12:45 |
Blog
José Sandoval: Socioeconomic inequalities in quality of life for patients with early breast cancer
José Sandoval, Clinical and Research Fellow at Curie Institute, shared on X: "Very happy that our…
Jun 22, 2024, 00:42 |
Blog
Results from AMEERA-5 published in Journal of Clinical Oncology
Paolo Tarantino shared a post on X: "Results from AMEERA-5 published in Journal of Clinical Oncology.…
Jun 21, 2024, 14:36 |
Insight
High ORR and low CRS rate with Linvoseltamab for R/R Multiple Myeloma
Recently Jeffrey Zonder shared a post on X about a recent paper by Naresh Bumma…
Jun 21, 2024, 02:08 |
Insight
New Paper Alert! AtezoTRIBE Study
AtezoTRIBE Study: Adding Atezolizumab to FOLFOXIRI/Bevacizumab Improves Survival in Metastatic Colorectal Cancer, Especially in Biomarker-Selected…
Jun 20, 2024, 07:36 |
Blog
LGBTQ+ patients report on their cancer care journey
Estela Rodriguez shared a post on X: "Disparities uncovered: LGBTQ+ patients report on their cancer care…
Jun 19, 2024, 14:22 |
Insight
Zhi Ven Fong: Our study as June’s Feature article in Annals of Surgery
Zhi Ven Fong, Pancreas and Liver surgeon at Mayo Clinic, shared on X: “Grateful to…
Jun 16, 2024, 19:29 |
Insight
Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study
Kristina Jenei, Associate Editor at the Journal of Cancer Policy, shared on X/Twitter: "New original…
Jun 16, 2024, 01:22 |
Insight
Ruzanna Papyan: Week 4 of the Global Access To Anti-GD2 Campaign
Ruzanna Papyan shared on LinkedIn: "Week 4 of the Global Access To Anti-GD2 Campaign This week,…
Jun 14, 2024, 14:08 |
Blog
Rami Manochakian: Results of PALOMA3 study by Natasha B. Leighl et al
Rami Manochakian shared a post on X: "Hot off the press. Just published in Journal of…
Jun 13, 2024, 15:48 |
Insight
Stephen Liu on a paper by Natasha Leighl, et al.
Stephen Liu recently shared a post on X: "PALOMA-3 results at Journal of Clinical Oncology…
Jun 13, 2024, 15:19 |
Blog
Recent news from Journal of Clinical Oncology about HR+/HER2-negative breast cancer - ASCO
ASCO (American Society of Clinical Oncology) shared a post on X/Twitter: ''Recent news from Journal…
Jun 12, 2024, 08:00 |
Insight
Erman Akkus on a paper by Ruben Malmberg, et al.
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: "Oral antihistamine…
Jun 10, 2024, 21:43 |
Blog
Ramy Sedhom: So glad to see this piece making waves again on Twitter
Ramy Sedhom shared a post by Rebecca Shatsky on X, adding the following: “So glad…
Jun 10, 2024, 15:00 |
Blog
Sumanta K. Pal: PIVOT09 comparing pegylated IL2/nivolumab to TKI by Nizar Tannir et al.
Sumanta K. Pal shared a post on X: “Huge congrats to Nizar Tannir, MD Anderson Cancer…
Jun 10, 2024, 11:09 |
Insight
Phase II BLOSSOM Trial Osimertinib in LMD from EGFR+ NSCLC by Sehhoon Park et al.
Jarushka Naidoo shared a post on X: "Phase II BLOSSOM Trial Osimertinib in LMD (leptomeningeal…
Jun 10, 2024, 01:42 |
Insight
Rebecca Shatsky: The Case for Focused Palliative Care Education in Oncology Training
Rebecca Shatsky shared on X/Twitter: "The Case for Focused Palliative Care Education in Oncology Training |…
Jun 9, 2024, 08:43 |
Insight
Daniel Stover: Activity post-breast cancer diagnosis: Is ‘exercise’ just ‘exercise’?
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
Jun 9, 2024, 06:07 |
Blog
Thomas J. Ettrich: Final results of our NIFE trial now published in 'Journal of Clinical Oncology'
Thomas J. Ettrich, Senior Physician, Department of Internal Medicine, University of Ulm, shared a post on…
Jun 8, 2024, 07:23 |
Opinion
Benjamin Toll: Interesting study about nausea prevention with olanzapine
Benjamin Toll, Associate Director of Education at MUSC Hollings Cancer Center, shared a post on…
Jun 4, 2024, 02:42 |
Insight
Stanley Ozogbo: Excited to share another abstract publication in the Journal of Clinical Oncology
Stanley Ozogbo, Resident Physician at Mercy Health, shared on X: "Excited to share another abstract publication…
May 30, 2024, 11:10 |
Blog
Fumiko Ladd Chino: It's the 2nd annual Yellow Dress Challenge for ASCO24
Fumiko Ladd Chino shared on X/Twitter: "I'm calling an ASCO Fashion audible for those still packing…
May 29, 2024, 15:32 |
Insight
Myeloma Paper of the Day, May 29th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Report of a modified Staging…
May 24, 2024, 14:53 |
Insight
Timothée Olivier: Our analysis tion about adjuvant use of CDK4/6 inhibitors in early breast cancer
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared a…
May 22, 2024, 15:11 |
Insight
Kimryn Rathmell: My editorial with Dr. Catherine Fahey highlighting a recent study by Dr. Joseph Unger
Kimryn Rathmell shared on X/Twitter: "A recent study by Dr. Joseph Unger, Fred Hutchinson Cancer Center +…
May 21, 2024, 12:01 |
Blog
Jarushka Naidoo: Phase III trial methylphenidate versus placebo for cancer fatigue in advanced solid tumors
Jarushka Naidoo shared on X/Twitter: "Phase III trial methylphenidate versus placebo for cancer fatigue in advanced…
May 17, 2024, 15:25 |
Blog
Andrea Necchi: Profoundly honored to serve as new Associate Editor Journal of Clinical Oncology
Andrea Necchi, Associate Professor of Oncology at Vita-Salute San Raffaele University, shared a post on…
May 17, 2024, 12:54 |
Insight
Piotr Wysocki: Anti-HER2 treatment in patients with advanced biliary cancer
Piotr Wysocki recently posted on LinkedIn: "The Targeted Agent and Profiling Utilization Registry (TAPUR) Study is…
May 16, 2024, 14:15 |
Insight
Elie G. Dib: Excited to share the results of the TAPUR study
Elie G. Dib, Associate Director of the Haematology-Oncology Training Program at Saint Joseph Mercy Hospital,…
May 14, 2024, 10:35 |
Insight
RELATIVITY-060 - summarized by Erman Akkus
Erman Akkus, Medical Oncology Fellow at Ankara University shared a post on X: “Adding relatlimab to…
May 13, 2024, 13:48 |
Blog
Rami Komrokji: Combining GenoMed and Moffitt database
Rami Komrokji, Vice chair of the Malignant Hematology Department and the head of the Leukemia…
May 12, 2024, 07:40 |
Insight
Yüksel Ürün: Excellent research on plasma Kidney Injury Molecule-1
Yüksel Ürün shared on X: "Congratulations to Wenxin Xu and the team for their excellent…
May 12, 2024, 07:10 |
Insight
Cathy Eng: Critical information from Journal of Clinical Oncology
Cathy Eng shared a post by Syed Ahmad, Director University of Cincinnati Cancer Center, on LinkedIn…
May 12, 2024, 04:15 |
Blog
Nico Gagelmann: Big achievement in JCO on timing of transplantation for patients with MDS
Nico Gagelmann, Chair of CAR-T for Plasma Cell Disorder Committee and Chair Trainee Committee at The…
May 9, 2024, 12:42 |
Blog
Estela Rodriguez: So much work to do to address barriers and develop pragmatic trials
Estela Rodriguez shared on X: “Only 7.1% of patients with cancer participate in clinical trials- so…
May 4, 2024, 10:53 |
Dialogues
OncoInfluencers: Dialogue with Tony Mok, hosted by Gevorg Tamamyan
Join us for an exciting new episode of “OncoInfluencers,” hosted by Dr. Gevorg Tamamyan. In this episode, we…
May 3, 2024, 16:39 |
Insight
Thor Halfdanarson: Cannabis in patients with cancer
Thor Halfdanarson, Medical Oncologist focusing on gastrointestinal malignancies at Mayo Clinic, shared on X/Twitter: "Cannabis…
May 1, 2024, 07:00 |
Insight
Piotr Wysocki: Cannabis and cannabinoid in adult cancer patients
Piotr Wysocki recently shared on LinkedIn: "ASCO guidelines devoted to cannabis and cannabinoid use in adult…
Apr 26, 2024, 20:26 |
Insight
New Paper Alert! Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial
Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial Authors:…
Apr 25, 2024, 21:06 |
Drugs
Piotr Wysocki: Datopotamab deruxtecan – another anti-TROP2 conjugate demonstrating activity in advanced ER+/HER2- and triple-negative breast cancer patients
Piotr Wysocki recently shared on LinkedIn: "Datopotamab deruxtecan – a novel anti-TROP2 conjugate demonstrates activity…
Apr 24, 2024, 09:13 |
Drugs
FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
FDA, the Food and Drug Administration, approved nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience, LLC) with…
Apr 19, 2024, 15:52 |
Drugs
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial
FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…
Apr 16, 2024, 11:25 |
Drugs
Piotr Wysocki: Adjuvant olaparib improves outcomes of breast cancer patients with germinal BRCA1/2 mutations at the cost of slightly decreased quality of life
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 15, 2024, 14:38 |
Insight
New Paper Alert! Refining Treatment Approaches in Early Breast Cancer Patients with Pathologic Complete Response
Refining Treatment Approaches in Early Breast Cancer Patients with Pathologic Complete Response Authors: Carmine Valenza,…
Apr 14, 2024, 03:52 |
Drugs
Piotr Wysocki: CLEAR trial – another study demonstrating that Immunotherapy and TKI combination should not be routinely recommended to favorable-risk RCC patients
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 12, 2024, 11:15 |
Insight
Robert Miller: How many adult patients with cancer participate in clinical trials?
Robert Miller, Chief Medical Science Officer at CancerLinQ, shared on LinkedIn: "How many adult patients…
Apr 8, 2024, 22:37 |
Insight
Key Message Highlights from Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma
Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous…
Apr 8, 2024, 08:41 |
Insight
Elizabeth Budde: We reported the longest follow-up of using BsAbs in lymphoma
Elizabeth Budde, Associate Professor at City of Hope, shared on X/Twitter: "We reported the longest…
Apr 8, 2024, 03:26 |
Insight
Lisa A. Lacasse: Researchers released new findings this week in the Journal of Clinical Oncology
Lisa A. Lacasse, President of the American Cancer Society Cancer Action Network (ASC CAN), shared…
Apr 7, 2024, 16:02 |
Blog
Emre Yekedüz: What a great news from ASCO!
Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University, made the following post on X:…
Apr 2, 2024, 18:56 |
Drugs
Shushan Hovsepyan: What is the optimal way of effective drug development for ultra-rare cancers?
Shushan Hovsepyan, Pediatric Oncologist and Research Coordinator at Yeolyan Hematology and Oncology Center, shared a…
Mar 31, 2024, 23:12 |
Insight
Stephen V Liu: Results from phase III CONTACT-01 trial Journal of Clinical Oncology
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Mar 30, 2024, 11:36 |
Insight
Piotr J. Wysocki: Pembrolizumab remains the only drug active in adjuvant settings in RCC – updated results of the ECOG-ACRIN E2810 on adjuvant pazopanib
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Mar 29, 2024, 18:54 |
Insight
Shushan Hovsepyan: Exploring new drugs for ultra-rare cancers?
Shushan Hovsepyan, Pediatric Oncologist and Research Coordinator at Yeolyan Hematology and Oncology Center, posted on…
Mar 28, 2024, 02:31 |
Insight
Rami Manochakian: New Supportive Care Guideline by ASCO on Vaccination of adult with cancer
Rami Manochakian, Thoracic Medical Oncologist at Mayo Clinic, shared a post on X: "Hot off…
Mar 24, 2024, 12:56 |
Career
Smita Bhatia Receives the 2024 ASCO-American Cancer Society Cancer Prevention Award
The American Society of Clinical Oncology (ASCO) has announced Smita Bhatia, MD, MPH, FASCO as the recipient…
Mar 22, 2024, 15:23 |
Blog
Piotr J. Wysocki: Regular, personalized follow-up in breast cancer survivors may not improve long-term outcomes but significantly improves patients’ quality of life
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a…
Mar 18, 2024, 19:36 |
Insight
Alisa Kamalyan: Our article "Cancer and Armed Conflict: Crossing Realities" remains relevant as various armed conflicts continue to unfold
Alisa Kamalyan, Head of Psychosocial Services at the Yeolyan Hematology and Oncology Center, posted on LinkedIn:…
Mar 18, 2024, 15:28 |
Blog
Vivek Subbiah: Universal germline, in addition to tumor somatic, genomic testing is needed to win the war against cancer
Vivek Subbiah recently shared a post on X/Twitter: “Pleased to share Universal Germline and Tumor…
Mar 16, 2024, 20:07 |
Insight
Erman Akkus: HER2 and mCRC on Journal of Clinical Oncology
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "HER2 and mCRC on…
Mar 16, 2024, 15:39 |
Blog
Sarah Sammons: DPYD testing is required before our pharmacy will dispense capecitabine
Sarah Sammons, Breast Medical Oncologist at Dana-Farber’s Breast Oncology Center, shared a post by Vivek Subbiah…
Mar 15, 2024, 18:27 |
Blog
Mehdi Hamadani: Much awaited Blood and Marrow Transplant Clinical Trials Network 1506 trial out in the Journal of Clinical Oncology
Mehdi Hamadani, Director of the Bone Marrow Transplantation and Cellular Therapy Program at the Medical…
Mar 15, 2024, 18:07 |
Insight
Talazoparib in Combination With Enzalutamide for Prostate Cancer - FDA Oncology
FDA Oncology posted on X/Twitter: "FDA Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment…
Mar 14, 2024, 09:38 |
Blog
Caryn Lerman: Dr. Heinz Josef Lenz and his team investigated the potential prognostic and predictive value of HER2 amplification and gene expression using NGS and NanoString data
Mar 5, 2024, 01:35 |
Insight
Timothée Olivier: Final results of ASCENT in patients with TNBC…
Timothée Olivier, Clinic Director at HUG – Geneva University Hospitals, shared the following post by Markus…
Mar 4, 2024, 17:27 |
Drugs
Piotr Wysocki: Anthracyclines must always be considered in the adjuvant treatment of breast cancer patients- final results of ABC trials
Piotr Wysocki, Professor of Medicine and Head of Department of Oncology at Jagiellonian University Hospital…
Mar 3, 2024, 01:59 |
Insight
Erman Akkus: Does primary tumor resection prolong OS in inoperable synchronous metastatic CRC?
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X: "Does primary tumor resection…
Mar 2, 2024, 23:40 |
Blog
Rami Manochakian: ASCO Living Guideline Update by great experts Journal of Clinical Oncology
Rami Manochakian, Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: “HOT OFF THE PRESS…
Feb 29, 2024, 19:29 |
Blog
Nuh Rahbari: The SYNCHRONOUS and CCReIV trials on primary tumor resection in metastatic colon cancer
Nuh Rahbari, Chairman and Professor of Surgery, Department of General and Visceral Surgery at University…
Feb 21, 2024, 17:10 |
Insight
Patients with breast cancer residing in areas with low opportunity have high allostatic load and worse mortality - Journal of Clinical Oncology
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
1
2
All:
128
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube